Employer Health Insurance Cost Increase 2026: Your Plan Will Cost 9.5% More — And GLP-1 Drugs Are Why

# Employer Health Insurance Cost Increase 2026: Your Plan Will Cost 9.5% More — And GLP-1 Drugs Are Why

> **Quick answer:** U.S. employer health care costs are on track to rise 9.5% in 2026, pushing average per-employee spending above $17,000 — the steepest jump in 15 years, according to consulting giant Aon. GLP-1 drugs like Wegovy and Ozempic are a central driver, now representing roughly 20% of all employer pharmacy costs. Your paycheck deduction and out-of-pocket expenses are almost certainly going up, and the decision many employers made about GLP-1 coverage is the reason why.

Your employer health insurance cost increase in 2026 is not a coincidence or a rounding error. It is the direct result of two colliding forces: a decade of deferred cost pressures finally landing all at once, and a class of blockbuster weight-loss and diabetes medications that are reshaping what American employers pay for health coverage. If you opened your benefits statement this year and did a double-take, here is exactly what happened — and what you can do about it.

## The 9.5% Number: What Aon's Data Actually Shows

Aon, one of the world's largest benefits consulting firms, projects that U.S. employer health care costs will rise **9.5% in 2026** — the largest single-year increase in approximately 15 years. The average total cost per employee is expected to exceed **$17,000**, up from roughly $15,860 in 2025.

That total breaks down across two payers: